[Prognostic factors of celiac disease occurrence in type 1 diabetes mellitus children]
Related Experiment Video
Updated: Jul 17, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Małgorzata Myśliwiec1, Anna Balcerska, Jan Stepiński
1Klinika Pediatrii, Hematologii, Onkologii i Endokrynologii AM w Gdańsku, Gdańsk. mysliwiec@amg.gda.pl
Insights
Celiac disease affects nearly 10% of children with type 1 diabetes (DM1). Tissue transglutaminase (TGA) antibody testing is the most sensitive method for screening celiac disease in this population.
Area of Science:
- Pediatric Endocrinology
- Gastroenterology
- Immunology
Context:
- Type 1 diabetes mellitus (DM1) and celiac disease frequently coexist in children.
- Standardizing diagnostic methods for celiac disease in DM1 patients is crucial.
- The Pomeranian region of Poland serves as the study's geographical focus.
Purpose:
- To determine the incidence of celiac disease among children with DM1 in Poland.
- To identify prognostic factors for celiac disease development in children with DM1.
- To evaluate the effectiveness of various serological markers for celiac disease screening.
Summary:
- A study involving 293 children with DM1 (newly diagnosed and long-standing) assessed celiac disease incidence and associated factors.
- Jejunal biopsies confirmed celiac disease in 5.7% of newly diagnosed and 9.4% of long-standing DM1 patients.
- Tissue transglutaminase (TGA) antibodies demonstrated the highest sensitivity (95.2%) for celiac disease detection in DM1 children.
Impact:
- Highlights the significant prevalence of celiac disease in children with DM1, underscoring the need for routine screening.
- Identifies TGA as a highly sensitive serological marker for early celiac disease detection in this high-risk group.
- Provides valuable data for clinical practice guidelines regarding the management of comorbidities in pediatric DM1.
Introduction:
Discussion on the frequency of coexistent celiac disease and type 1 diabetes mellitus (DM1) as well as an attempt to standardize diagnostic methods of celiac disease detection among DM1 children have been performed.
Objectives:
To assess the incidence of celiac disease among DM1 children in the Pomeranian region of Poland followed by analysis of the putative prognostic factors for celiac disease development in this particular group of children.
Materials And Methods:
70 children aged 9.47+/-4.59 (group 1) de novo diagnosed with DM1 and 223 children aged 10.20+/-3.87 with long-standing diabetes mellitus type 1 (4.47+/-3.16 years from the diagnosis) were enrolled in the study. All the patients had C-peptide, HbA1c, CRP, TSH, fT4, fT3, urinary albumin secretion rate, IgA, level of antigliadin antibodies (AGA), anti-tissue transglutaminase (TGA) IgA and IgG antibodies (ELISA), anti-endomysium (EmA) IgA and IgG antibodies (immunofluorescence) and anti-tyreoglobulin antibodies (TG), anti-thyroid peroxidase (TPO) antibodies (ELISA) evaluated. All the patients had jejunal biopsy and thyroid ultrasound examination.
Results:
5.7% of group 1 patients were diagnosed with celiac disease based on the positive jejunal biopsy in comparison with 9.4% in the group 2. TGA antibodies were present in 9.52% of group 2, AGA in 7.62%, EmA in 6.19%. 10% of group 1 children had autoimmune thyroiditis versus 24.2% of group 2 children. The group of children with coincident long-lasting DM1 and celiac disease (group A) was characterized by significantly earlier age at diagnosis (p=0.003), higher HbA(1)c (p=<0.001), CRP (p<0.001) and elevated urine albumin secretion in relation to children without celiac disease and autoimmune thyroiditis (group B). Serologic test detecting TGA antibodies was found to be the most sensitive (95.2%) for the detection of celiac disease among DM1 children, while the lowest sensitivity was obtained in the case of the EmA antibody test (61.9%).
Conclusions:
The celiac disease morbidity confirmed by jejunal biopsy is high among DM1 children (9.4%). The assessment of the serum TGA appears to be the most sensitive screening marker for the celiac disease detection in DM1 children.
More Related Videos
Related Concept Videos
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations
Type II Diabetes I: Introduction

